Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria
NCT04015557 · Status: SUSPENDED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2021-06-30
Summary
In homocystinuria due to cystathionine beta synthase (CBS) deficiency or classical homocystinuria, decreased blood cysteine levels are observed. Cysteine is essential for the synthesis of molecules such as glutathione and taurine. Main functions of glutathione are to detoxify drugs and to scavenge reactive oxygen species. N-acetylcysteine is a commercially available drug chemically similar to cysteine. In CBS deficient animal models, N-acetylcysteine supplementation improves cysteine and liver glutathione concentrations. N-acetylcysteine also acts directly as a scavenger of free radicals. In CBS deficiency, increased oxidative damage has been described and possibly contributes to the clinical manifestations of CBS deficiency. Acetaminophen (Paracetamol) is a common painkiller and its overdose (\>4 g/day) is a major cause of acute liver failure. Glutathione is required for Acetaminophen detoxification, and the preferred treatment for an overdose is the administration of N-acetylcysteine.
The aim of this study is to demonstrate that CBS deficiency patients have glutathione depletion and to investigate if Acetaminophen can induce subclinical liver damage and if N-acetylcysteine supplementation could prevent the toxic-effects of acetaminophen.
The investigators' hypothesis is that CBS deficiency patients have an inadequate supply of cysteine for the glutathione synthesis, which impairs antioxidants defenses and increases risk of intoxication of drugs that require glutathione, such as Acetaminophen. This potential increased liver toxicity induced by drugs or other xenobiotics that are detoxified by the glutathione pathway has not been explored in CBS deficiency patients. The experiments should provide answers about the functional role of cysteine and glutathione depletion in CBS deficiency and if N-acetylcysteine might have a place as an adjunct therapy for CBS deficiency.
Conditions
- CBS Deficiency
Interventions
- DRUG
-
Adult patients with homocystinuria due to cystathionine beta synthase (CBS) deficiency and controls will receive a single dose of Acetaminophen (1.5g) orally. Blood will be drawn at time 0, 2, 4, 6 and 8 hours after the acetaminophen dose to measure liver enzymes and markers of oxidative stress.
- DRUG
-
N-acetylcysteine
Patients with homocystinuria due to cystathionine beta synthase (CBS) deficiency and controls will receive again a normal dose of acetaminophen (1.5g) orally and one hour later oral N-acetylcysteine (70 mg per kilogram of body weight). Blood will be drawn at time 0, 2, 4, 6 and 8 hours after the acetaminophen dose to measure liver enzymes and markers of oxidative stress.
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
collaborator OTHER -
Hospital de Clinicas de Porto Alegre
lead OTHER
Principal Investigators
-
Ida VD Schwartz, PhD · Professor
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-11
- Primary Completion
- 2022-06-30
- Completion
- 2022-12-01
Countries
- Brazil
Study Locations
More Related Trials
-
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
NCT02583672 ·Status: COMPLETED ·Phase: PHASE2
-
Glutathione and Its Precursors in HIV-Infected Patients
NCT00910442 ·Status: COMPLETED ·Phase: PHASE2
-
DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease
NCT02286856 ·Status: COMPLETED ·Phase: NA
-
Metabolic Analysis in Human Sulfur Amino Acid Deficiency
NCT00253760 ·Status: COMPLETED ·Phase: NA
-
Dietary Effects of Sulfur Amino Acids
NCT00228618 ·Status: COMPLETED
-
Oral Glutathione Supplementation on the Levels of Blood Glutathione
NCT01044277 ·Status: COMPLETED ·Phase: NA
-
The Effects of N-acetylcysteine on Performance and Redox Homeostasis
NCT03121222 ·Status: COMPLETED ·Phase: PHASE2
-
Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B
NCT00858273 ·Status: COMPLETED ·Phase: NA
-
Adduct Dipstick for Diagnosis of Acetaminophen Toxicity
NCT01575847 ·Status: COMPLETED
-
Dietary Methionine and Cysteine Restriction in Healthy Adults
NCT02192437 ·Status: COMPLETED ·Phase: NA
-
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NCT04542161 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems
NCT00889538 ·Status: COMPLETED ·Phase: NA
-
The Impact of Qualia Gluthathione+ on Blood Glutathione Levels
NCT07221955 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels
NCT01251315 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sachet
NCT07302828 ·Status: COMPLETED ·Phase: NA
-
Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis
NCT00227058 ·Status: COMPLETED ·Phase: NA
-
Glutathione and Health With Post-Polio Syndrome
NCT01402570 ·Status: COMPLETED ·Phase: NA
-
Glutathione (GSH) Supplementation After Hospitalization
NCT03166371 ·Status: WITHDRAWN ·Phase: NA
-
Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents
NCT04005053 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
NCT05371288 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?
NCT01692639 ·Status: TERMINATED
-
L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde
NCT02524262 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of N-Acetyl Cysteine in Children With Autism
NCT00627705 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Liposomal Glutathione Supplementation in Healthy Subjects
NCT02278822 ·Status: COMPLETED ·Phase: NA
-
Survey on Supplement Use in Mitochondrial Disease
NCT02311257 ·Status: COMPLETED